Literature DB >> 3935209

Metronidazole and Indian kala-azar: results of a clinical trial.

M Mishra, B D Thakur, M Choudhary.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935209      PMCID: PMC1418421          DOI: 10.1136/bmj.291.6509.1611

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Co-trimoxazole for leishmaniasis-or metronidazole?

Authors:  J Masramon; J Aubia; J Lloveras; I Llorach; M Llorach
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

2.  Co-trimoxazole for systemic leishmaniasis.

Authors:  K J Murphy; A C Bong
Journal:  Lancet       Date:  1981-02-07       Impact factor: 79.321

3.  An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.

Authors:  R A Neal; S L Croft
Journal:  J Antimicrob Chemother       Date:  1984-11       Impact factor: 5.790

4.  Inefficacy of metronidazole in experimental infections of Leishmania donovani, L. mexicana, and Trypanosoma brucei brucei.

Authors:  J S Keithly; S G Langreth
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

  4 in total
  4 in total

1.  Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Authors:  J P Gangneux; M Dullin; A Sulahian; Y J Garin; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Chemotherapy of leishmaniasis in India.

Authors:  C P Thakur
Journal:  Indian J Pediatr       Date:  1987 Jan-Feb       Impact factor: 1.967

3.  Co-trimoxazole for visceral leishmaniasis.

Authors:  A Rodriguez-Cuartero; F J Pérez-Blanco; A López-Fernández
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

4.  Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease.

Authors:  Arvind K Chavali; Anna S Blazier; Jose L Tlaxca; Paul A Jensen; Richard D Pearson; Jason A Papin
Journal:  BMC Syst Biol       Date:  2012-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.